What Happened?
Tampa, -based HedgePath-Pharmaceuticals Promoted Garrison Hasara as Chief Compliance Officer
About the Company
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.
About the Person
Garrison Hasara is Chief Compliance Officer at HedgePath Pharmaceuticals. Previously, Garrison held various senior legal leadership roles in the industry.
Info Source
News
Short Profile